Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Espinel-Ingroff, V. Chaturvedi, A. Fothergill, M. Rinaldi (2002)
Optimal Testing Conditions for Determining MICs and Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Uncommon Molds: NCCLS Collaborative StudyJournal of Clinical Microbiology, 40
N. Almyroudis, D. Sutton, A. Fothergill, M. Rinaldi, S. Kusne (2007)
In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal AgentsAntimicrobial Agents and Chemotherapy, 51
C. García-Vidal, A. Upton, K. Kirby, K. Marr (2008)
Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 47 8
A. Espinel-Ingroff, A. Fothergill, M. Ghannoum, E. Manavathu, L. Ostrosky-Zeichner, M. Pfaller, M. Rinaldi, W. Schell, T. Walsh (2007)
Quality Control and Reference Guidelines for CLSI Broth Microdilution Method (M38-A Document) for Susceptibility Testing of Anidulafungin against MoldsJournal of Clinical Microbiology, 45
C. Lass‐Flörl, G. Kofler, G. Kropshofer, J. Hermans, A. Kreczy, M. Dierich, D. Niederwieser (1998)
In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.The Journal of antimicrobial chemotherapy, 42 4
S. Messer, D. Diekema, R. Hollis, L. Boyken, S. Tendolkar, J. Kroeger, M. Pfaller (2007)
Evaluation of Disk Diffusion and Etest Compared to Broth Microdilution for Antifungal Susceptibility Testing of Posaconazole against Clinical Isolates of Filamentous FungiJournal of Clinical Microbiology, 45
A. Espinel-Ingroff (2003)
Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991)Journal of Clinical Microbiology, 41
A. Espinel-Ingroff (2008)
In vitro susceptibility testing: when, where, and what to useJ Invasive Fungal Infect, 2
M. Pfaller, S. Messer, L. Boyken, C. Rice, S. Tendolkar, R. Hollis, D. Diekema (2008)
In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus SpeciesJournal of Clinical Microbiology, 46
A. Espinel-Ingroff, A. Fothergill, J. Peter, M. Rinaldi, T. Walsh (2002)
Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative StudyJournal of Clinical Microbiology, 40
J. Rodríguez-Tudela, L. Alcazar-Fuoli, E. Mellado, A. Alastruey‐Izquierdo, A. Monzón, M. Cuenca‐Estrella (2008)
Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 52
D. Denning, S. Radford, K. Oakley, L. Hall, E. Johnson, D. Warnock (1997)
Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.The Journal of antimicrobial chemotherapy, 40 3
T. Novicki, Karen Lafe, L. Bui, U. Bui, Robert Geise, K. Marr, B. Cookson (2003)
Genetic Diversity among Clinical Isolates of Acremonium strictum Determined during an Investigation of a Fatal MycosisJournal of Clinical Microbiology, 41
J. Meletiadis, C. Antachopoulos, Theodouli Stergiopoulou, S. Pournaras, E. Roilides, T. Walsh (2007)
Differential Fungicidal Activities of Amphotericin B and Voriconazole against Aspergillus Species Determined by Microbroth MethodologyAntimicrobial Agents and Chemotherapy, 51
B. Castiglioni, D. Sutton, J. Fung, S. Kusne (2002)
Pseudallescheria boydii (Anamorph Scedosporium apiospermum) Infection in Solid Organ Transplant Recipients in a Tertiary Medical Center and Review of the LiteratureMedicine, 81
E. Snelders, H.A. Lee, J. Kuijpers (2008)
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanismPLoS Med, 5
A. Espinel-Ingroff, Elizabeth Johnson, H. Hockey, P. Troke (2008)
Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.The Journal of antimicrobial chemotherapy, 61 3
E. Alvarado-Ramírez, J. Torres-Rodríguez (2007)
In Vitro Susceptibility of Sporothrix schenckii to Six Antifungal Agents Determined Using Three Different MethodsAntimicrobial Agents and Chemotherapy, 51
J. Pfaller, S. Messer, R. Hollis, D. Diekema, M. Pfaller (2003)
In Vitro Susceptibility Testing of Aspergillus spp.: Comparison of Etest and Reference Microdilution Methods for Determining Voriconazole and Itraconazole MICsJournal of Clinical Microbiology, 41
A. Espinel-Ingroff, M. Bartlett, R. Bowden, N. Chin, C. Cooper, A. Fothergill, M. Mcginnis, P. Menezes, S. Messer, P. Nelson, F. Odds, L. Pasarell, J. Peter, M. Pfaller, J. Rex, M. Rinaldi, G. Shankland, T. Walsh, I. Weitzman (1997)
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungiJournal of Clinical Microbiology, 35
A. Espinel-Ingroff (2008)
Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi.Revista iberoamericana de micologia, 25 2
Subcommittee Testing (2008)
EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 14 10
J. Rex, Clinical (2009)
Method for antifungal disk diffusion susceptibility testing of yeasts : Approved guideline
Qiu Sun, L. Najvar, R. Bocanegra, D. Loebenberg, J. Graybill (2002)
In Vivo Activity of Posaconazole against Mucor spp. in an Immunosuppressed-Mouse ModelAntimicrobial Agents and Chemotherapy, 46
A. Espinel-Ingroff, K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, V. Paetznick, J. Peter, M. Rinaldi (1995)
Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungiAntimicrobial Agents and Chemotherapy, 39
E. Martín-Mazuelos, J. Pemán, A. Valverde, M. Chaves, M. Serrano, E. Cantón (2003)
Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.The Journal of antimicrobial chemotherapy, 52 3
A. Espinel-Ingroff (2006)
Comparison of Three Commercial Assays and a Modified Disk Diffusion Assay with Two Broth Microdilution Reference Assays for Testing Zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with Posaconazole and Amphotericin BJournal of Clinical Microbiology, 44
(2007)
Academic Editor: Chris Kibbler, Royal Free Hospital London, United Kingdom
A. Espinel-Ingroff, A. Fothergill, M. Ghannoum, E. Manavathu, L. Ostrosky-Zeichner, M. Pfaller, M. Rinaldi, W. Schell, T. Walsh (2005)
Quality Control and Reference Guidelines for CLSI Broth Microdilution Susceptibility Method (M38-A Document) for Amphotericin B, Itraconazole, Posaconazole, and VoriconazoleJournal of Clinical Microbiology, 43
M. Arendrup, S. Perkhofer, S. Howard, G. García-Effrón, Aimanianda Vishukumar, D. Perlin, C. Lass‐Flörl (2008)
Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus EchinocandinsAntimicrobial Agents and Chemotherapy, 52
S. Krishnan-Natesan, P. Chandrasekar, G. Alangaden, E. Manavathu (2008)
Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.International journal of antimicrobial agents, 32 6
E. Rocha, G. García-Effrón, Steven Park, D. Perlin (2007)
A Ser678Pro Substitution in Fks1p Confers Resistance to Echinocandin Drugs in Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 51
G. García-Effrón, A. Dilger, L. Alcazar-Fuoli, Steven Park, E. Mellado, D. Perlin (2008)
Rapid Detection of Triazole Antifungal Resistance in Aspergillus fumigatusJournal of Clinical Microbiology, 46
F. Odds, M. Motyl, Roberto Andrade, J. Billé, E. Cantón, M. Cuenca‐Estrella, A. Davidson, C. Durussel, D. Ellis, E. Foraker, A. Fothergill, M. Ghannoum, R. Giacobbe, M. Gobernado, R. Handke, M. Laverdière, Wendy Lee-Yang, W. Merz, L. Ostrosky-Zeichner, J. Pemán, S. Perea, J. Perfect, M. Pfaller, L. Proia, J. Rex, M. Rinaldi, J. Rodríguez-Tudela, W. Schell, C. Shields, D. Sutton, P. Verweij, D. Warnock (2004)
Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus SpeciesJournal of Clinical Microbiology, 42
V. Petraitis, R. Petraitienė, A. Groll, Kristin Roussillon, M. Hemmings, C. Lyman, Tin Sein., J. Bacher, I. Bekersky, T. Walsh (2002)
Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic RabbitsAntimicrobial Agents and Chemotherapy, 46
M. Serrano, M. Ramírez, D. Morilla, A. Valverde, M. Chávez, A. Espinel-Ingroff, R. Claro, Agustín Fernández, C. Almeida, E. Martín-Mazuelos (2004)
A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.The Journal of antimicrobial chemotherapy, 53 5
M. Linares, Guadalupe Charriel, F. Solís, F. Rodríguez, A. Ibarra, M. Casal (2005)
Susceptibility of Filamentous Fungi to Voriconazole Tested by Two Microdilution MethodsJournal of Clinical Microbiology, 43
P. Troke, K. Aguirrebengoa, C. Arteaga, D. Ellis, C. Heath, I. Lutsar, M. Rovira, Quoc Nguyen, M. Slavin, S. Chen (2008)
Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 PatientsAntimicrobial Agents and Chemotherapy, 52
A. Espinel-Ingroff, A. Rezusta (2002)
E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution MethodJournal of Clinical Microbiology, 40
V. Chaturvedi, M. Pfaller, D. Sheehan, T. Walsh (2008)
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
D. Neofytos, D. Neofytos, D. Horn, E. Anaissie, W. Steinbach, A. Olyaei, J. Fishman, M. Pfaller, C. Chang, K. Webster, K. Marr, K. Marr (2009)
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 48 3
J. Rex, Clinical (2008)
Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard
J. Rodríguez-Tudela, M. Arendrup, F. Barchiesi, J. Billé, E. Chryssanthou, M. Cuenca‐Estrella, E. Dannaoui, D. Denning, J. Donnelly, F. Dromer, W. Fegeler, C. Lass‐Flörl, C. Moore, M. Richardson, P. Sandven, A. Velegraki, P. Verweij (2008)
EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)∗Clinical Microbiology and Infection, 14
A. Espinel-Ingroff, E. Cantón (2008)
Comparison of Neo-Sensitabs Tablet Diffusion Assay with CLSI Broth Microdilution M38-A and Disk Diffusion Methods for Testing Susceptibility of Filamentous Fungi with Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and VoriconazoleJournal of Clinical Microbiology, 46
C. Castro, M. Serrano, Bernardo Flores, A. Espinel-Ingroff, E. Martín-Mazuelos (2004)
Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with a Modified NCCLS M38-A Method To Determine the Activity of Voriconazole against Clinical Isolates of Aspergillus sppJournal of Clinical Microbiology, 42
D. Neofytos, D. Horn, E. Anaissie (2009)
Epidemiology and outcome of invasive fungal infections in adult hematopoietic stem cell transplant recipients: analysis of multicenter PATH Alliance RegistryClin Infect Dis, 48
M. Pfaller, D. Diekema, M. Ghannoum, J. Rex, Barbara Alexander, David Andes, Steven Brown, Vishnu Chaturvedi, A. Espinel-Ingroff, Cynthia Fowler, Elizabeth Johnson, C. Knapp, M. Motyl, Luis Ostrosky-Zeichner, Daniel Sheehan, Thomas Walsh (2009)
Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution MethodsJournal of Clinical Microbiology, 47
A. Espinel-Ingroff, B. Arthington-Skaggs, N. Iqbal, David Ellis, M. Pfaller, S. Messer, M. Rinaldi, Annette Fothergill, D. Gibbs, A. Wang (2007)
Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and CaspofunginJournal of Clinical Microbiology, 45
A. Espinel-Ingroff, M. Bartlett, V. Chaturvedi, M. Ghannoum, K. Hazen, M. Pfaller, M. Rinaldi, T. Walsh (2001)
Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative EvaluationAntimicrobial Agents and Chemotherapy, 45
A. Espinel-Ingroff (2001)
Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous FungiJournal of Clinical Microbiology, 39
M. Torres-Narbona, J. Guinea, J. Martínez‐Alarcón, T. Peláez, E. Bouza (2006)
In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the EtestAntimicrobial Agents and Chemotherapy, 51
E. Mellado, G. García-Effrón, L. Alcazar-Fuoli, W. Melchers, P. Verweij, M. Cuenca‐Estrella, J. Rodríguez-Tudela (2007)
A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A AlterationsAntimicrobial Agents and Chemotherapy, 51
T. Walsh, I. Raad, T. Patterson, P. Chandrasekar, G. Donowitz, R. Graybill, R. Greene, R. Hachem, S. Hadley, R. Herbrecht, A. Langston, A. Louie, P. Ribaud, B. Segal, D. Stevens, J. Burik, C. White, G. Corcoran, J. Gogate, G. Krishna, L. Pedicone, C. Hardalo, J. Perfect (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 44 1
G. Blum, S. Perkhofer, H. Haas, Markus Schrettl, R. Würzner, M. Dierich, C. Lass‐Flörl (2008)
Potential Basis for Amphotericin B Resistance in Aspergillus terreusAntimicrobial Agents and Chemotherapy, 52
The Clinical and Laboratory Standards Institute (CLSI) has standardized broth microdilution and disk diffusion methodology for testing filamentous fungi (molds) that cause invasive disease. Quality control MIC (minimal inhibitory concentration) and MEC (minimal effective concentration; echinocandins only) limits are also available in the recently published CLSI M38-A2 document. Although breakpoints based on correlations of in vitro results and clinical outcome have not been established, MIC or MEC and zone diameter categories for five antifungal agents and various mold species, as well as epidemiologic cutoffs for Aspergillus fumigatus versus the triazoles, have been recently documented. Some insights of the potential clinical value of reference methods also have been reported. During the past few years, the potential utility of various commercial methods has been evaluated by comparing them with reference methodology. This review summarizes and discusses the advantages and disadvantages of these developments.
Current Fungal Infection Reports – Springer Journals
Published: Aug 26, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.